Skip to content
healthcare.dev

Ondansetron

NDC 70518-1551, Ondansetron, tablet, orally disintegrating, from REMEDYREPACK INC..

Product NDC
70518-1551
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1551 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON8 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
70518-1551-0705181551006 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (70518-1551-0)
70518-1551-1705181551013 BLISTER PACK in 1 CARTON (70518-1551-1) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/18063a64-a4c0-4bad-911b-00df5c7bb65d

Use it

Look up 70518-1551 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1551 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-1551. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.